TrkB modulators (Hermo Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTrkB modulators (Hermo Pharma)
Drug Alias Nametyrosine receptor kinase B modulators (Herma Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 modulators
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHermo Pharma Oy Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHermo Pharma Oy LtdUniversity Of Helsinki
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A